The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

Dupixent (dupilumab) achieved a five-fold greater sustained remission rate at 36 weeks than placebo in the study – 20% versus 4% – meaning that the skin lesions had been resolved, with no ...

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...

An artificial intelligence-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times. DERM (Deep Ensemble for ...

"The survival advantage was particularly evident in patients with alopecia areata and Sjögren's syndrome, and remained ...

Such cases are common in the growing population of older adults, where the incidence of nonmelanoma skin cancer is high and factors such ... effectively clearing the lesion and avoiding potential ...

And per the American Academy of Dermatology Association, sometimes skin changes like rashes, “netting”, and the appearance of lumps can reveal underlying heart issues, too. The British Journal of ...